This company has been marked as potentially delisted and may not be actively trading. Exscientia (EXAI) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock EXAI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period NVIDIA Invested in These 2 AI Stocks, Should You? (EXAI)Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.December 2, 2024 | marketbeat.comExscientia and Recursion Merge to Revolutionize Drug DiscoveryNovember 21, 2024 | markets.businessinsider.comRecursion, Exscientia officially combine to advance drug discoveryNovember 21, 2024 | markets.businessinsider.comRecursion: No News Isn't Good News When It Comes To Vanilla PipelineNovember 20, 2024 | seekingalpha.comBarclays Sticks to Its Hold Rating for Exscientia Plc (EXAI)November 15, 2024 | markets.businessinsider.comExscientia (NASDAQ:EXAI) Shares Down 5.3% - Time to Sell?November 15, 2024 | marketbeat.comRecursion and Exscientia Merger Approved by ShareholdersNovember 14, 2024 | markets.businessinsider.comRecursion Pharmaceuticals: Recursion and Exscientia Shareholders Approve the Proposed CombinationNovember 13, 2024 | finanznachrichten.deRecursion, Exscientia shareholders approve proposed combinationNovember 13, 2024 | markets.businessinsider.comBaillie Gifford & Co. Has $18.78 Million Stake in Exscientia plc (NASDAQ:EXAI)November 13, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Sees Large Volume Increase - Here's WhyNovember 11, 2024 | marketbeat.comExscientia Plc Enhances Board Collaboration with RecursionNovember 6, 2024 | markets.businessinsider.comExscientia (NASDAQ:EXAI) Shares Gap Down - Here's WhyOctober 21, 2024 | marketbeat.comExscientia plc (NASDAQ:EXAI) Sees Large Decrease in Short InterestOctober 17, 2024 | marketbeat.comVet tranquillizer increases overdose deaths in Yukon, health minister saysOctober 12, 2024 | msn.comBoeing Sacks 17,000 Workers Amid Strike and Safety ConcernsOctober 12, 2024 | nz.finance.yahoo.comRecursion’s All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug DiscoveryOctober 11, 2024 | msn.comCapricor reports positive long-term data for DMD drug deramiocelOctober 11, 2024 | msn.comExscientia Set for Strategic Acquisition by RecursionOctober 11, 2024 | finance.yahoo.comRecursion, Exscientia seek support for merger ahead of special meetingOctober 10, 2024 | seekingalpha.comExscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024October 9, 2024 | businesswire.comExscientia (NASDAQ:EXAI) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.com13,086,600 Shares in Exscientia plc (NASDAQ:EXAI) Bought by Novo Holdings A SSeptember 30, 2024 | marketbeat.comAI Revolution in Healthcare Gains Momentum as FDA Prepares for Tech BoomSeptember 24, 2024 | theglobeandmail.comMorgan Stanley Sticks to Its Hold Rating for Exscientia Plc (EXAI)September 24, 2024 | markets.businessinsider.comExscientia (NASDAQ:EXAI) Trading Up 3.8%September 18, 2024 | marketbeat.comExscientia plc (NASDAQ:EXAI) Shares Bought by Bank of New York Mellon CorpSeptember 18, 2024 | marketbeat.comRecursion: AI Is Only As Good As The DataSeptember 11, 2024 | seekingalpha.comExscientia (NASDAQ:EXAI) Stock Price Down 3.5%September 9, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Shares Up 4.5%September 4, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Sees Unusually-High Trading VolumeSeptember 3, 2024 | marketbeat.comShort Interest in Exscientia plc (NASDAQ:EXAI) Grows By 15.7%September 2, 2024 | marketbeat.comExscientia Plc (EXAI): A Penny Stock That Will Make You a MillionaireAugust 31, 2024 | msn.comExscientia (NASDAQ:EXAI) Shares Gap Up to $5.66August 30, 2024 | marketbeat.comExscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 28, 2024 | finance.yahoo.comExscientia (NASDAQ:EXAI) Stock Price Down 4.2%August 27, 2024 | marketbeat.comExscientia plc (NASDAQ:EXAI) Stake Cut by Baillie Gifford & Co.August 25, 2024 | marketbeat.comExscientia plc (NASDAQ:EXAI) Short Interest Down 12.4% in JulyAugust 19, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 2.8%August 19, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Issues Quarterly Earnings ResultsAugust 18, 2024 | marketbeat.comNews Flash: 4 Analysts Think Exscientia plc (NASDAQ:EXAI) Earnings Are Under ThreatAugust 16, 2024 | finance.yahoo.comMaintaining Hold Rating on Exscientia Plc Amid Anticipated Developments and Clinical MilestonesAugust 16, 2024 | markets.businessinsider.comHow A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market UpdatesAugust 15, 2024 | theglobeandmail.comExscientia Business Update for Second Quarter and First Half 2024August 15, 2024 | finance.yahoo.comBarclays Downgrades Exscientia plc - Depositary Receipt () (EXAI)August 14, 2024 | msn.comExscientia (NASDAQ:EXAI) Receives Equal Weight Rating from BarclaysAugust 13, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 3.1%August 13, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Shares Gap Down to $5.05August 12, 2024 | marketbeat.comTD Cowen Downgrades Exscientia plc - Depositary Receipt () (EXAI)August 9, 2024 | msn.comExscientia (NASDAQ:EXAI) Stock Rating Reaffirmed by TD CowenAugust 9, 2024 | marketbeat.com Get Exscientia News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAI and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAI Media Mentions By Week EXAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAI News Sentiment▼0.000.90▲Average Medical News Sentiment EXAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAI Articles This Week▼03▲EXAI Articles Average Week Get Exscientia News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mirum Pharmaceuticals News Today Xenon Pharmaceuticals News Today AMNEAL PHARMACEUTICALS News Today Bausch Health Cos News Today Apellis Pharmaceuticals News Today Arrowhead Pharmaceuticals News Today Vericel News Today Twist Bioscience News Today Kiniksa Pharmaceuticals International News Today Recursion Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAI) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exscientia plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exscientia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXAI Stock Alerts